James Scibetta

James S.
Scibetta currently works at VectorY BV, as Chief Executive Officer & Director from 2024.
Mr. Scibetta also formerly worked at Maverick Therapeutics, Inc., as Chief Executive Officer & Director from 2017 to 2021, ImmuneID, Inc., as President, CEO, Treasurer & Director from 2021 to 2023, Nephros, Inc., as Chairman from 2007 to 2013, Labopharm, Inc., as Director from 2001 to 2008, Aquestive Therapeutics, Inc., as Independent Director from 2017 to 2022, Matinas BioPharma Holdings, Inc., as Independent Director from 2013 to 2025, Bioenvision, Inc., as Chief Financial Officer from 2006 to 2007, Pacira Biosciences, Inc., as President from 2016 to 2017, and Merrimack Pharmaceuticals, Inc., as Chief Financial Officer & Executive Vice President from 1998 to 2006.
Mr. Scibetta received his undergraduate degree from Wake Forest University and Masters Business Admin degree from the University of Michigan.